Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 8/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.34 |
| ▸ | CCR3 | P51677 | 2/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15478333 | 0.91 | DRD2 (0.40) | CCR1DRD2OPRM1OPRL1CCR3 | |
| SCHEMBL15478375 | 0.89 | CCR1 (0.50) | CCR1DRD2OPRM1OPRL1CCR3 | |
| SCHEMBL15478359 | 0.89 | CCR1 (0.38) | CCR1DRD2OPRM1OPRL1CCR3 | |
| SCHEMBL15478400 | 0.85 | CCR1 (0.37) | CCR1DRD2OPRM1CCR3ADRA1A | |
| SCHEMBL15478363 | 0.84 | CCR1 (0.34) | CCR1DRD2OPRM1OPRL1ADRA1A | |
| SCHEMBL14419960 | 0.84 | DRD2 (0.37) | CCR1DRD2OPRM1OPRL1CCR3 | |
| SCHEMBL15478335 | 0.84 | DRD2 (0.34) | CCR1DRD2OPRM1OPRL1ADRA1A | |
| SCHEMBL15478403 | 0.83 | DRD2 (0.36) | CCR1DRD2OPRM1OPRL1SIGMAR1 | |
| SCHEMBL15478401 | 0.83 | CCR1 (0.37) | CCR1DRD2OPRM1OPRL1CCR3 | |
| SCHEMBL18895930 | 0.81 | CCR1 (0.43) | CCR1DRD2OPRM1OPRL1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8653096-B2 | Chemokine receptor antagonists and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2014-02-18 | — | — | US | disclosed |